CD44 as a cancer stem cell marker and its prognostic value in patients with ovarian carcinoma
Author:
Affiliation:
1. Department of Gynaecology and Obstetrics, University Hospital Pilsen, Charles University, Prague, Czech Republic;
2. Sikl’s Department of Pathology, University Hospital Pilsen, Charles University, Prague, Czech Republic
Funder
Specific student research grant of Charles University in Prague
Publisher
Informa UK Limited
Subject
Obstetrics and Gynaecology
Link
https://www.tandfonline.com/doi/pdf/10.1080/01443615.2017.1336753
Reference20 articles.
1. Expression of CD44S and CD44v5 Is More Common in Stage III Than in Stage I Serous Ovarian Carcinomas
2. CD44 is the principal cell surface receptor for hyaluronate
3. Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma
4. Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer
5. Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dysgerminoma germ cell tumors exhibit high expression of PD-L1 and are associated with high levels of tumor-infiltrating lymphocytes and a good patient prognosis;2024-06-11
2. A paclitaxel-hyaluronan conjugate (ONCOFID-P-B™) in patients with BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the tumor microenvironment;Journal of Experimental & Clinical Cancer Research;2024-04-10
3. Nanoarchitectonics of doxycycline-loaded vitamin E–D-α-tocopheryl polyethylene glycol 1000 succinate micelles for ovarian cancer stem cell treatment;Nanomedicine;2023-09
4. CD44 Is a Prognostic Biomarker Correlated With Immune Infiltrates and Metastasis in Clear Cell Renal Cell Carcinoma;Anticancer Research;2023-07-26
5. A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer;Frontiers in Endocrinology;2023-06-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3